Case number 1:20-cv-01286
Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 518 in lead case no. 19-1938-LPS) Associated Cases: 1:19-cv-01964-LPS, 1:20-cv-01286-LPS (ntl) |
| Jun 28, 2022 | 18 | Patent/Trademark Report to Commissioner (4) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Mar 4, 2022 | 17 | Redacted Document (5) Docket Text: REDACTED VERSION of (15 in 1:20-cv-01286-LPS, 447 in 1:19-cv-01938-LPS) Stipulation, SO ORDERED, by Alkem Laboratories Ltd.. (Gattuso, Dominick) |
| Mar 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01286-LPS, 447 in 1:19-cv-01938-LPS) [SEALED] STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (Alkem). Signed by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01286-LPS (ntl) |
| Mar 1, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Feb 28, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that in anticipation of reassignment of these cases to another judge, the parties shall meet and confer and, no later than tomorrow, March 1, submit a joint status report (one that collectively addresses all of these related cases), advising the Court of the following (in addition to anything else the parties wish to report): (i) how many and which patents are at issue in any of these cases; (ii) how many applications or how many filers are at issue, in total, across these cases; (iii) how many contested infringement allegations remain to be litigated; (iv) how many invalidity issues are to be litigated; (v) when do any applicable stays (e.g., 30-month stay) expire; (vi) how long do the parties anticipate the upcoming bench trial to be; and (vii) how important is it that trial occur on or around July 25, 2022, as currently scheduled? ORDERED by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01286-LPS, 1:20-cv-01763-LPS, 1:22-cv-00221-LPS (ntl) |
| Jan 18, 2022 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Alkem Laboratories Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendant Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) |
| Sep 7, 2021 | 13 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Amy D. Brody as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick) |
| Jan 21, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys William A. Rakoczy, Amy D. Brody, Lauren M. Lesko for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 19, 2021 | 12 | Answer to Counterclaim (7) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven) |
| Jan 12, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Amy D. Brody, and Lauren M. Lesko of Rakoczy Molino Mazzochi Siwik LLP filed by Alkem Laboratories Ltd., [11] MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. (ntl) |
| Dec 31, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (17) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Dec 30, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Amy D. Brody, and Lauren M. Lesko of Rakoczy Molino Mazzochi Siwik LLP - filed by Alkem Laboratories Ltd.. (Gattuso, Dominick) |
| Dec 29, 2020 | 8 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, with Jury Demand Alkem Laboratories Ltd.'s Answer, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Alkem Laboratories Ltd..(Gattuso, Dominick) |
| Dec 29, 2020 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Gattuso, Dominick) |
| Oct 1, 2020 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S: For Alkem Laboratories Ltd. waiver sent on 9/30/2020, answer due 12/29/2020. (Balick, Steven) |
| Sep 30, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:20-cv-01286-LPS, 1:20-cv-01287-LPS, 1:20-cv-01295-LPS, 1:20-cv-01296-LPS, 1:20-cv-01297-LPS (rjb) |
| Sep 25, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (sam) |
| Sep 24, 2020 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3222894.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(sam) |
| Sep 24, 2020 | 1 | Exhibit A-B (57) |
| Sep 24, 2020 | 1 | Civil Cover Sheet (4) |
| Sep 24, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Sep 24, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (sam) |
| Sep 24, 2020 | 4 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 11, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/10/2023. (sam) |
| Sep 24, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (sam) |
| Sep 24, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (sam) |
| Sep 24, 2020 | 1 | Complaint* (1) |
